Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study

Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study Publisher Pubmed

Sepanlou S¹ ; Najafi F² ; Poustchi H³ ; Parsaeian M⁴ ; Ahmadi A⁵ ; Somi M⁶ ; Moradpour F⁷ ; Alizadehnavaei R⁸ ; Gohari A⁹ ; Zamani B¹⁰ ; Esmaeilinadimi A¹¹ ; Rezaianzadeh A¹² ; Mansourghanaei F¹³ ; Bahramali E¹⁴ Show All Authors

Sepanlou S¹
Najafi F²
Poustchi H³
Parsaeian M⁴
Ahmadi A⁵
Somi M⁶
Moradpour F⁷
Alizadehnavaei R⁸
Gohari A⁹
Zamani B¹⁰
Esmaeilinadimi A¹¹
Rezaianzadeh A¹²
Mansourghanaei F¹³
Bahramali E¹⁴
Ansarimoghaddam A¹⁵
Hamzeh B²
Zanganeh Yousefabadi E¹⁶
Zare Sakhvidi MJ¹⁷
Mohebbi I¹⁸
Fattahi MR¹⁹
Nejatizadeh A²⁰
Marioryad H²¹
Motamedgorji N³
Roozafzai F³
Eghtesad S³
Mohammadi Z³
Shayanrad A³
Sharafkhah M³
Etemadi A²²
Kamangar F²³
Juraschek SP²⁴
Malekzadeh R²⁵

Show Affiliations

1. Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
2. Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
3. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
5. Department of Epidemiology and Biostatistics, Modeling in Health Research Center, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran
6. Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
7. Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
8. Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
9. Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
10. Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
11. Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
12. Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
13. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
14. Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
15. Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
16. Department of Internal Medicine, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
17. Occupational Health Research Centre, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
18. Social Determinants of Health Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran
19. Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
20. Molecular Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
21. Yasuj University of Medical Sciences, Yasuj, Iran
22. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States
23. Department of Biology, School of Computer, Mathematical, and Natural Sciences, Morgan State University, Baltimore, MD, United States
24. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States
25. Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, North Kargar Ave., Tehran, 14117-13135, Iran

Source: Scientific Reports Published:2022

Abstract

In this cross-sectional population-based study, we used the baseline data of the Prospective Epidemiologic Research Studies in IrAN cohort study collected in Iran from 2014 to 2020. The main outcomes were the prevalence of hypertension and proportion of awareness, treatment, and control based on the 2017 ACC/AHA guideline compared to the seventh report of the Joint National Committee (JNC7). Of the total of 163,770 participants, aged 35–70 years, 55.2% were female. The sex-age standardized prevalence of hypertension was 22.3% (95% CI 20.6, 24.1) based on the JNC7 guideline and 36.5% (31.1, 41.8) based on the ACC/AHA guideline. A total of 24,312 participants [14.1% (10.1, 18.1)] were newly diagnosed based on the ACC/AHA guideline. Compared to adults diagnosed with hypertension based on the JNC7 guideline, the newly diagnosed participants were mainly young literate males who had low levels of risk factors and were free from conventional comorbidities of hypertension. About 30.7% (25.9, 35.4) of them (4.3% of the entire population) were eligible for pharmacologic intervention based on the ACC/AHA guideline. Implementation of the new guideline may impose additional burden on health systems. However, early detection and management of elevated blood pressure may reduce the ultimate burden of hypertension in Iran. © 2022, The Author(s).

Related Docs

View other Related Docs

1. Impact of 2017 Acc/Aha Guideline on Prevalence, Awareness, Treatment, Control, and Determinants of Hypertension: A Population-Based Cross-Sectional Study in Southwest of Iran, Population Health Metrics (2021)

2. Status of Hypertension in Tehran: Potential Impact of the Acc/Aha 2017 and Jnc7 Guidelines, 2012–2015, Scientific Reports (2019)

3. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115Mmhg, 1990-2015, JAMA - Journal of the American Medical Association (2017)

4. Prevalence, Awareness, Treatment, and Control of Hypertension Among Adult Residents of Tehran: The Tehran Cohort Study, Global Heart (2022)

5. Insight Into Blood Pressure Targets for Universal Coverage of Hypertension Services in Iran: The 2017 Acc/Aha Versus Jnc 8 Hypertension Guidelines, BMC Public Health (2020)

6. Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on Jnc-Iv and 2017 Acc/Aha Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (Tlgs), Risk Management and Healthcare Policy (2020)

7. Antihypertensive Drug Effects on Long-Term Blood Pressure: An Individual-Level Data Meta-Analysis of Randomised Clinical Trials, Heart (2022)

8. The Effects of L-Carnitine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-Analysis, Clinical Therapeutics (2024)

Experts (# of related papers)

View all Related Experts

Hossein Poustchi (11)

Reza Malekzadeh (8)

Style	Citing Format
MLA	Sepanlou S, et al.. "Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study." Scientific Reports, vol. 12, no. 1, 2022, pp. -.
APA	Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, Moradpour F, Alizadehnavaei R, Gohari A, Zamani B, Esmaeilinadimi A, Rezaianzadeh A, Mansourghanaei F, Bahramali E, Ansarimoghaddam A, Hamzeh B, Zanganeh Yousefabadi E, Zare Sakhvidi MJ, Mohebbi I, ... Malekzadeh R (2022). Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study. Scientific Reports, 12(1), -.
Chicago	Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, Moradpour F, et al.. "Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study." Scientific Reports 12, no. 1 (2022): -.
Harvard	Sepanlou S et al. (2022) 'Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study', Scientific Reports, 12(1), pp. -.
Vancouver	Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, et al.. Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study. Scientific Reports. 2022;12(1):-.
BibTex	@article{ author = {Sepanlou S and Najafi F and Poustchi H and Parsaeian M and Ahmadi A and Somi M and Moradpour F and Alizadehnavaei R and Gohari A and Zamani B and Esmaeilinadimi A and Rezaianzadeh A and Mansourghanaei F and Bahramali E and Ansarimoghaddam A and Hamzeh B and Zanganeh Yousefabadi E and Zare Sakhvidi MJ and Mohebbi I and Fattahi MR and Nejatizadeh A and Marioryad H and Motamedgorji N and Roozafzai F and Eghtesad S and Mohammadi Z and Shayanrad A and Sharafkhah M and Etemadi A and Kamangar F and Juraschek SP and Malekzadeh R}, title = {Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study}, journal = {Scientific Reports}, volume = {12}, number = {1}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Sepanlou S AU - Najafi F AU - Poustchi H AU - Parsaeian M AU - Ahmadi A AU - Somi M AU - Moradpour F AU - Alizadehnavaei R AU - Gohari A AU - Zamani B AU - Esmaeilinadimi A AU - Rezaianzadeh A AU - Mansourghanaei F AU - Bahramali E AU - Ansarimoghaddam A AU - Hamzeh B AU - Zanganeh Yousefabadi E AU - Zare Sakhvidi MJ AU - Mohebbi I AU - Fattahi MR AU - Nejatizadeh A AU - Marioryad H AU - Motamedgorji N AU - Roozafzai F AU - Eghtesad S AU - Mohammadi Z AU - Shayanrad A AU - Sharafkhah M AU - Etemadi A AU - Kamangar F AU - Juraschek SP AU - Malekzadeh R TI - Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study JO - Scientific Reports VL - 12 IS - 1 SP - EP - PY - 2022 ER -

Style

Citing Format

MLA

Sepanlou S, et al.. "Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study." Scientific Reports, vol. 12, no. 1, 2022, pp. -.

APA

Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, Moradpour F, Alizadehnavaei R, Gohari A, Zamani B, Esmaeilinadimi A, Rezaianzadeh A, Mansourghanaei F, Bahramali E, Ansarimoghaddam A, Hamzeh B, Zanganeh Yousefabadi E, Zare Sakhvidi MJ, Mohebbi I, ... Malekzadeh R (2022). Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study. Scientific Reports, 12(1), -.

Chicago

Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, Moradpour F, et al.. "Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study." Scientific Reports 12, no. 1 (2022): -.

Harvard

Sepanlou S et al. (2022) 'Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study', Scientific Reports, 12(1), pp. -.

Vancouver

Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, et al.. Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study. Scientific Reports. 2022;12(1):-.

BibTex

@article{ author = {Sepanlou S and Najafi F and Poustchi H and Parsaeian M and Ahmadi A and Somi M and Moradpour F and Alizadehnavaei R and Gohari A and Zamani B and Esmaeilinadimi A and Rezaianzadeh A and Mansourghanaei F and Bahramali E and Ansarimoghaddam A and Hamzeh B and Zanganeh Yousefabadi E and Zare Sakhvidi MJ and Mohebbi I and Fattahi MR and Nejatizadeh A and Marioryad H and Motamedgorji N and Roozafzai F and Eghtesad S and Mohammadi Z and Shayanrad A and Sharafkhah M and Etemadi A and Kamangar F and Juraschek SP and Malekzadeh R}, title = {Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study}, journal = {Scientific Reports}, volume = {12}, number = {1}, pages = {-}, year = {2022} }

RIS

TY - JOUR
AU - Sepanlou S
AU - Najafi F
AU - Poustchi H
AU - Parsaeian M
AU - Ahmadi A
AU - Somi M
AU - Moradpour F
AU - Alizadehnavaei R
AU - Gohari A
AU - Zamani B
AU - Esmaeilinadimi A
AU - Rezaianzadeh A
AU - Mansourghanaei F
AU - Bahramali E
AU - Ansarimoghaddam A
AU - Hamzeh B
AU - Zanganeh Yousefabadi E
AU - Zare Sakhvidi MJ
AU - Mohebbi I
AU - Fattahi MR
AU - Nejatizadeh A
AU - Marioryad H
AU - Motamedgorji N
AU - Roozafzai F
AU - Eghtesad S
AU - Mohammadi Z
AU - Shayanrad A
AU - Sharafkhah M
AU - Etemadi A
AU - Kamangar F
AU - Juraschek SP
AU - Malekzadeh R
TI - Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study
JO - Scientific Reports
VL - 12
IS - 1
SP -
EP -
PY - 2022
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract